LLY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eli Lilly and Co

Watchlist Manager

Watchlist

Price: 990.9 EUR 0.79% Market Closed

Market Cap: €941.8B

E	Eli Lilly and Co XMUN:LLY	US
F	Fennec Pharmaceuticals Inc F:RV41	US
M	Mega Lifesciences PCL SET:MEGA	TH
F	FirstEnergy Corp SWB:FE7	US
C	CNH Industrial NV F:37C	UK
D	Deutsche Post AG XHAM:DPW	DE

Profitability Summary

Eli Lilly and Co's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

81%

Gross Margin is Increasing

78% > 83%

Exceptional Operating Margin

47%

Strong 3Y Average Operating Margin

37%

Operating Margin is Increasing

26% > 47%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

21% > 35%

Exceptional Free Cash Flow Margin

14%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

14% > 14%

Exceptional ROE

108%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

21%

ROIC is Increasing

15% > 29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.